Navigation Links
Vion Reports 2007 Fourth Quarter and Year-End Results
Date:3/17/2008

mpany implemented a one-for-ten reverse split of all outstanding shares of its common stock and a corresponding decrease in the number of shares of authorized common stock. Share and per share amounts contained herein are provided on a post-split basis.

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine(R) (VNP40101M), a unique alkylating agent, is being evaluated in a Phase II pivotal trial as a single agent in elderly patients with previously untreated de novo poor-risk acute myelogenous leukemia. Clinical trials of Cloretazine(R) (VNP40101M) with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, particularly Cloretazine(R) (VNP40101M), delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to c
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
2. Renovis Reports Fourth Quarter and Full Year 2007 Financial Results
3. Warner Chilcott Reports the Death of Its Director James Andress
4. Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
5. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
6. Unigene Restates Policy on Analyst Reports
7. NPS Pharmaceuticals Reports 2007 Financial Results
8. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
9. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
10. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
11. MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... WOODBRIDGE, N.J. , Feb. 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... a trade secrets lawsuit against Genewiz Inc. in excess ... obtained and utilized GenScript,s trade secrets, and that it ... court entered an order denying motions for judgment notwithstanding ...
(Date:2/26/2015)... , Feb. 26, 2015 Protiviti ( ... latest version of the Governance Portal , designed ... risk and compliance (GRC) tasks across multiple business units ... updated to help customers better align their controls with ... Treadway Commission ) requirements. In response to client feedback, ...
(Date:2/26/2015)... The healthcare landscape is rapidly and radically changing. ... will host its 20 th Anniversary Medical Technologies ... to 10, at the Hilton San Diego Resort and Spa ... This event is a platform for global medical devices, diagnostics, ... and how to succeed in an uncertain future. ...
(Date:2/26/2015)... 26, 2015 RURO, Inc., a leading ... version 6.2 – the latest update to the bestselling ... that of a quick and easy method to gain ... latest version, RURO engineering has enhanced the system’s support ... large amounts of sample records. , "FreezerPro has ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Embrace the Future of Medical Technologies with Frost & Sullivan 2Embrace the Future of Medical Technologies with Frost & Sullivan 3RURO Releases FreezerPro® version 6.2 2
... , , , ... leading systems biology tools company, announced today that they ... International Society for Interferon and Cytokine Research (www.isicr.org). These ... and chemical pathway interactions. Each map describes multi-step signaling ...
... SYDNEY, July 21 /PRNewswire-Asia/ -- Pharmaxis Ltd (ASX: ... the afternoon of Wednesday,22nd July 2009. Dr Alan Robertson ... quarter and answer investor questions. , ... (Sydney),(Wednesday 22nd July at 6.00pm U.S. East Coast, 3.00pm U.S. ...
... Guo and his team of researchers for the project discovered a ... is pitch black, not by paint, but by using incredibly intense ... that shines upon it. "With the creation of the ... us, which may open up a whole new horizon for various ...
Cached Biology Technology:GeneGo Donates Proprietary Cytokine Pathway Maps to ISICR 2Laser technology creates new forms of metal and enhances aircraft performance 2
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... . . With the aid of ... Center for Nanophase Materials Sciences, scientists have made ... pathways for nanoscale electronics. The study, published in ... led by Ramamoorthy Ramesh of Lawrence Berkeley National ...
... DURHAM, N.C. -- To avoid creating greenhouse gases, ... leave land unfarmed in conservation reserves than to plow ... a comprehensive Duke University-led study. "Converting set-asides to ... mitigation policy that should not be encouraged until ethanol-production ...
... to train and educate scientists on the latest tools, ... Institute,s (JCVI) Eukaryotic Genome Annotation and Analysis Team will ... United States Agriculture Department (USDA) scientists at the Agricultural ... on the use of JCVI,s eukaryotic annotation methods, and ...
Cached Biology News:Story tips from the Departments of Energy's Oak Ridge National Lab -- March 2009 2Story tips from the Departments of Energy's Oak Ridge National Lab -- March 2009 3Study critiques corn-for-ethanol's carbon footprint 2Study critiques corn-for-ethanol's carbon footprint 3JCVI program trains USDA scientists on eukaryotic genome analysis 2
... The 200RT rotary tables offer precision ... is mount compatible with Parkers linear positioners ... height in multi-axis configurations., , Preloaded, ... rotation , Dual race preloaded angular contact ...
Wnt-1 (G-19)...
TGF-beta 1,-2,-3 MAb (Clone 1D11)...
ACAT-1 (H-125)...
Biology Products: